These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16297858)

  • 1. Downregulation of MDM2 expression by RNAi inhibits LoVo human colorectal adenocarcinoma cells growth and the treatment of LoVo cells with mdm2siRNA3 enhances the sensitivity to cisplatin.
    Yu Y; Sun P; Sun LC; Liu GY; Chen GH; Shang LH; Wu HB; Hu J; Li Y; Mao YL; Sui GJ; Sun XW
    Biochem Biophys Res Commun; 2006 Jan; 339(1):71-8. PubMed ID: 16297858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Knock-down of apollon gene by antisense oligodeoxynucleotide inhibits the proliferation of Lovo cells and enhances chemo-sensitivity].
    He JH; Zhang XY; Wu FY; Liao XL; Wang W; Jiang JW
    Yao Xue Xue Bao; 2011 Feb; 46(2):138-45. PubMed ID: 21542283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effects of small interfering RNA targeting MDM2 on human osteosarcoma cells].
    Lü JY; Gao ZL; Wang JC; Wu DK; Zhao DX; Zhang DD; Zhao YY
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):502-5. PubMed ID: 19062715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
    Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity.
    Li MY; Zhu M; Feng F; Cai FY; Fan KC; Jiang H; Wang ZQ; Linghu EQ
    Genet Mol Res; 2014 Apr; 13(3):6981-94. PubMed ID: 24782214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic suppression of prostatic cancer cells by coexpression of both murine double minute 2 small interfering RNA and wild-type p53 gene in vitro and in vivo.
    Ji K; Wang B; Shao YT; Zhang L; Liu YN; Shao C; Li XJ; Li X; Hu JD; Zhao XJ; Xu DQ; Li Y; Cai L
    J Pharmacol Exp Ther; 2011 Jul; 338(1):173-83. PubMed ID: 21444629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of MACC1 expression enhances cisplatin sensitivity in SKOV-3/DDP cells.
    Chen ZM; Shi HR; Li X; Deng YX; Zhang RT
    Genet Mol Res; 2015 Dec; 14(4):17134-44. PubMed ID: 26681060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on functions and mechanism of curcumin in inducing colorectal carcinoma cells LoVo apoptosis].
    Guo LD; Jiao ZX; Song Y; Teng WH; Liu Z; Liu JZ
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2191-6. PubMed ID: 24079252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
    Xu L; Huang Y; Chen D; He J; Zhu W; Zhang Y; Liu X
    Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo.
    Gu J; Tang Y; Liu Y; Guo H; Wang Y; Cai L; Li Y; Wang B
    Cancer Lett; 2014 Feb; 343(2):200-9. PubMed ID: 24161623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide sensitizes the cytotoxicity of human colorectal carcinoma cells toward cisplatin via enhancing apoptosis pathways in vitro and in vivo.
    Lin HH; Shi MD; Tseng HC; Chen JH
    Toxicol Sci; 2014 May; 139(1):108-20. PubMed ID: 24563380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA.
    Jiang T; Zhou C; Gu J; Liu Y; Zhao L; Li W; Wang G; Li Y; Cai L
    Cancer Lett; 2013 Aug; 337(1):133-42. PubMed ID: 23726840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW; Yu X; Liu T; Yu SY; Chen DJ
    Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
    Hu S; Hu CP; Liang CH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels.
    Giovannetti E; Backus HH; Wouters D; Ferreira CG; van Houten VM; Brakenhoff RH; Poupon MF; Azzarello A; Pinedo HM; Peters GJ
    Br J Cancer; 2007 Mar; 96(5):769-75. PubMed ID: 17339891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
    Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
    Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.